ZBH
Zimmer Biomet Holdings, Inc. Healthcare - Medical Devices Investor Relations →
Zimmer Biomet Holdings, Inc. (ZBH) closed at $93.93 as of 2026-07-31, trading 12.7% below its 200-week moving average of $107.65. This places ZBH in the extreme value zone. The stock moved further from the line this week, up from -15.2% last week. The 14-week RSI sits at 54, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.82 ratio) is neutral — neither side is clearly dominating.
Over the past 1257 weeks of data, ZBH has crossed below its 200-week moving average 18 times. On average, these episodes lasted 26 weeks. Historically, investors who bought ZBH at the start of these episodes saw an average one-year return of +10.2%.
With a market cap of $18.2 billion, ZBH is a large-cap stock. The company generates a free cash flow yield of 5.8%, which is healthy. Return on equity stands at 6.1%. The stock trades at 1.4x book value.
The company has been aggressively buying back shares, reducing its share count by 6.5% over the past three years.
Over the past 24.1 years, a hypothetical investment of $100 in ZBH would have grown to $299, compared to $1270 for the S&P 500. ZBH has returned 4.7% annualized vs 11.1% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 10% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ZBH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ZBH Crosses Below the Line?
Across 18 historical episodes, buying ZBH when it crossed below its 200-week moving average produced an average return of +8.0% after 12 months (median +13.0%), compared to +8.9% for the S&P 500 over the same periods. 72% of those episodes were profitable after one year. After 24 months, the average return was +9.8% vs +20.7% for the index.
Each line shows $100 invested at the moment ZBH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices ZBH would reach each dislocation threshold.
Dislocation Price Levels
Prices where ZBH's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $80.93 | Unusually cheap — potential buy zone |
| Value | +1σ | $85.10 | Cheap vs. own history |
| Fair Value | +0σ | $89.72 | Historical mean behavior |
| Expensive | -1σ | $94.88 | Expensive vs. own history |
| Deep Expensive | -2σ | $100.67 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from ZBH's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
ZBH has crossed below its 200-week MA 18 times with an average 1-year return of +10.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2002 | Jul 2002 | 2 | 3.5% | +47.6% | +259.6% |
| Apr 2006 | Aug 2006 | 15 | 17.3% | +44.7% | +74.2% |
| Oct 2007 | Jan 2008 | 14 | 15.0% | -37.0% | +60.4% |
| Feb 2008 | Mar 2008 | 2 | 0.3% | -53.5% | +45.5% |
| Apr 2008 | Jan 2011 | 145 | 53.3% | -40.2% | +46.9% |
| Aug 2011 | Jan 2012 | 22 | 15.2% | +16.0% | +105.9% |
| Nov 2016 | Nov 2016 | 1 | 1.8% | +13.9% | +7.0% |
| Nov 2016 | Dec 2016 | 1 | 0.1% | +15.3% | +4.6% |
| Mar 2018 | Apr 2018 | 5 | 5.2% | +18.9% | -3.4% |
| May 2018 | May 2018 | 1 | 0.2% | +4.0% | -6.8% |
| Jun 2018 | Jul 2018 | 1 | 0.1% | +6.5% | -7.3% |
| Jul 2018 | Jul 2018 | 1 | 0.1% | +11.5% | -7.5% |
| Nov 2018 | Jan 2019 | 10 | 12.0% | +28.7% | -8.5% |
| Mar 2020 | May 2020 | 10 | 28.7% | +68.2% | +4.4% |
| Jun 2020 | Jul 2020 | 3 | 3.6% | +44.6% | -11.9% |
| Nov 2021 | Apr 2023 | 73 | 20.6% | -8.0% | -21.7% |
| May 2023 | Jun 2023 | 2 | 1.7% | -8.1% | -24.2% |
| Jul 2023 | Ongoing | 157+ | 24.5% | Ongoing | -23.5% |
| Average | 26 | — | +10.2% | — |
Frequently Asked Questions
Is ZBH below its 200-week moving average?
Yes. As of 2026-07-31, Zimmer Biomet Holdings, Inc. (ZBH) is trading 12.7% below its 200-week moving average of $107.65. The current price is $93.93.
What is ZBH's 200-week moving average price?
Zimmer Biomet Holdings, Inc.'s 200-week moving average is $107.65 as of 2026-07-31. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ZBH drops below its 200-week moving average?
ZBH has crossed below its 200-week moving average 18 times in our data. On average, buying at that moment produced a one-year return of +10.2%. These dips have historically been decent entry points. These episodes lasted 26 weeks on average.
Is ZBH a good value right now?
Here's what our data says about ZBH as of 2026-07-31: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 54. Free cash flow yield is 5.8%. Return on equity is 6.1%. Price-to-book is 1.4x. This is not a buy or sell recommendation — always do your own research.
How does ZBH compare to the S&P 500?
Over the past 24.1 years, $100 invested in ZBH would have grown to $299, compared to $1270 for the S&P 500. That's 4.7% annualized vs 11.1% for the index. ZBH has underperformed the broader market over this period.
Does ZBH pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. currently pays a dividend yield of 101.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-07-31